key: cord-0745088-uoifla20
authors: Taylor, Peter; Allen, Lowri; Shrikrishnapalasuriyar, Natasha; Stechman, Michael; Rees, Aled
title: Vaccine‐induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage
date: 2021-07-08
journal: Clin Endocrinol (Oxf)
DOI: 10.1111/cen.14548
sha: b3f8a52e1bc5e7ff9243ad7b59d2e65441b734f5
doc_id: 745088
cord_uid: uoifla20

nan

Whilst attention has largely been focused on cerebral venous sinus thrombosis in this disorder, thrombotic and bleeding complications can also occur at other sites. Here, we report the case of a patient with VITT in whom adrenal haemorrhage was the presenting pathology.

A 38-year-old male with no significant medical history and no family history of clotting disorders attended the emergency unit with sudden onset of severe abdominal pain and vomiting. He had received his first dose of the ChAdOx1 vaccine 8 days prior.

Observations were normal and his abdomen was nontender.

Investigations revealed an elevated white cell count (19.1 × 10 9 /L; predominantly neutrophils) and mild thrombocytopenia (139 × 10 9 /L). Electrolytes, amylase, renal and liver function were normal, as was fibrinogen concentration and prothrombin/activated partial thromboplastin times. Blood lactate was elevated at 5 mmol/L. Plain abdominal X-ray was unremarkable but computed tomography abdomen showed retroperitoneal fat stranding and high-density fluid surrounding the adrenal glands, in keeping with haemorrhage ( Figure 1A) . A random cortisol immediately following the scan was 61 nmol/L, hence intravenous hydrocortisone 50 mg tds was commenced.

The platelet count fell profoundly over the following days to a nadir of 14 × 10 9 /L. D-dimer concentration was markedly raised (>20,000 µg/L; normal <500) and heparin-induced thrombocytopenia To our knowledge, this is the first published case of bilateral adrenal haemorrhage due to VITT. Our case serves as a reminder to clinicians that VITT may present with bilateral adrenal haemorrhage, with symptoms that are nonspecific and biochemistry at the presentation that is not classically 'Addisonian'. Prompt recognition and early treatment, including timely administration of glucocorticoid and mineralocorticoid replacement, is likely to lead to improved outcomes. Experience to date

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

suggests that VITT behaves similarly to autoimmune HIT in which bilateral adrenal haemorrhage has been reported previously. 1-3 Adrenal infarction usually presents as a haemorrhage, with the unique vascular anatomy of a plentiful arterial inflow but only a single central adrenal vein accounting for the vulnerability of the gland to infarction. Whilst adrenal insufficiency in HIT is generally considered irreversible, recovery of adrenal function has been described. 4 Therefore, the need for ongoing steroid substitution in VITT-associated adrenal haemorrhage should be assessed at regular intervals. Finally, whilst our case illustrates a rare complication of the ChAdOx1 vaccine, the incidence of VITT is still very low, with the benefits of vaccination far outweighing any risk of thrombosis. Nevertheless, the predilection for VITT to affect young adults as in our case supports recent UK Governmental advice to use nonadenoviralbased vaccines in individuals under 40 wherever possible.

Additionally, given that the use of COVID-19 vaccines remains in the early stages, this case serves as a reminder that all such adverse outcomes should be reported to postadministration surveillance programs following national processes and Medicines and Healthcare products Regulatory Agency guidance. Endocrinologists therefore have a critical role in both reporting these cases and ensuring appropriate long-term monitoring. We also hope that this report will act as a stimulus for national and international collaborations to better define the demographics and natural history of VITT-associated adrenal haemorrhage and other potential endocrine complications. 

Bilateral adrenal hemorrhage associated with heparin-induced thrombocytopenia

Bilateral adrenal hemorrhage: the unrecognized cause of hemodynamic collapse associated with heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia after total knee arthroplasty, with subsequent adrenal hemorrhage

Restoration of adrenal function after bilateral adrenal damage due to heparin-induced thrombocytopenia (HIT): a case report